Biroccio A - Search Results

1

Identification of novel RHPS4-derivative ligands with improved toxicological profiles and telomere-targeting activities.

Rizzo A, Iachettini S, Zizza P, Cingolani C, Porru M, Artuso S, Stevens M, Hummersone M, Biroccio A, Salvati E, Leonetti C. Rizzo A, et al. Among authors: biroccio a. J Exp Clin Cancer Res. 2014 Oct 6;33(1):81. doi: 10.1186/s13046-014-0081-x. J Exp Clin Cancer Res. 2014. PMID: 25288403 Free PMC article.

2

Bcl-2 overexpression enhances the metastatic potential of a human breast cancer line.

Del Bufalo D, Biroccio A, Leonetti C, Zupi G. Del Bufalo D, et al. Among authors: biroccio a. FASEB J. 1997 Oct;11(12):947-53. doi: 10.1096/fasebj.11.12.9337147. FASEB J. 1997. PMID: 9337147

3

N-methylformamide induces changes on adhesive properties and lung-colonizing potential of M14 melanoma cells.

Del Bufalo D, Leonetti C, Bucci B, Amedeo C, Falcioni R, Biroccio A, Zupi G. Del Bufalo D, et al. Among authors: biroccio a. Br J Cancer. 1998;77(2):210-5. doi: 10.1038/bjc.1998.35. Br J Cancer. 1998. PMID: 9460990 Free PMC article.

4

Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.

Leonetti C, Biroccio A, Candiloro A, Citro G, Fornari C, Mottolese M, Del Bufalo D, Zupi G. Leonetti C, et al. Among authors: biroccio a. Clin Cancer Res. 1999 Sep;5(9):2588-95. Clin Cancer Res. 1999. PMID: 10499637

5

Encapsulation of c-myc antisense oligodeoxynucleotides in lipid particles improves antitumoral efficacy in vivo in a human melanoma line.

Leonetti C, Biroccio A, Benassi B, Stringaro A, Stoppacciaro A, Semple SC, Zupi G. Leonetti C, et al. Among authors: biroccio a. Cancer Gene Ther. 2001 Jun;8(6):459-68. doi: 10.1038/sj.cgt.7700326. Cancer Gene Ther. 2001. PMID: 11498766

6

Bcl-2 overexpression decreases BCNU sensitivity of a human glioblastoma line through enhancement of catalase activity.

Del Bufalo D, Trisciuoglio D, Biroccio A, Marcocci L, Buglioni S, Candiloro A, Scarsella M, Leonetti C, Zupi G. Del Bufalo D, et al. Among authors: biroccio a. J Cell Biochem. 2001 Aug 21-Sep 5;83(3):473-83. doi: 10.1002/jcb.1245. J Cell Biochem. 2001. PMID: 11596115

7

Reconstitution of hTERT restores tumorigenicity in melanoma-derived c-Myc low-expressing clones.

Biroccio A, Amodei S, Benassi B, Scarsella M, Cianciulli A, Mottolese M, Del Bufalo D, Leonetti C, Zupi G. Biroccio A, et al. Oncogene. 2002 May 2;21(19):3011-9. doi: 10.1038/sj.onc.1205415. Oncogene. 2002. PMID: 12082531

8

Alpha-tocopherol protects against cisplatin-induced toxicity without interfering with antitumor efficacy.

Leonetti C, Biroccio A, Gabellini C, Scarsella M, Maresca V, Flori E, Bove L, Pace A, Stoppacciaro A, Zupi G, Cognetti F, Picardo M. Leonetti C, et al. Among authors: biroccio a. Int J Cancer. 2003 Mar 20;104(2):243-50. doi: 10.1002/ijc.10933. Int J Cancer. 2003. PMID: 12569582

9

Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy.

Pace A, Savarese A, Picardo M, Maresca V, Pacetti U, Del Monte G, Biroccio A, Leonetti C, Jandolo B, Cognetti F, Bove L. Pace A, et al. Among authors: biroccio a. J Clin Oncol. 2003 Mar 1;21(5):927-31. doi: 10.1200/JCO.2003.05.139. J Clin Oncol. 2003. PMID: 12610195 Clinical Trial.

10

The future of antisense therapy: combination with anticancer treatments.

Biroccio A, Leonetti C, Zupi G. Biroccio A, et al. Oncogene. 2003 Sep 29;22(42):6579-88. doi: 10.1038/sj.onc.1206812. Oncogene. 2003. PMID: 14528283 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters